급성 뇌실외배액(EVD) 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 용도별, 환자 유형별, 지역별, 경쟁별(2020-2030년)

Global Acute External Ventricular Drain Market was valued at USD 252.34 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.40% through 2030. The global healthcare industry has been witnessing a steady rise in the demand for neurosurgical procedures and devices, and one such critical device that plays a pivotal role in the management of patients with intracranial conditions is the Acute External Ventricular Drain (EVD). EVDs are indispensable tools for monitoring and managing cerebrospinal fluid (CSF) levels, intracranial pressure (ICP), and assisting in various neurosurgical procedures. The global Acute External Ventricular Drain market has been experiencing significant growth over the past few years and is expected to continue its upward trajectory.

Key Market Drivers

Rising Incidence of Neurological Disorders

The Global Acute External Ventricular Drain (EVD) Market has been experiencing steady growth in recent years, driven by a combination of factors that reflect the increasing prevalence of neurological disorders, advancements in medical technology, and a growing aging population. In 2021, over 3 billion individuals globally were affected by neurological conditions, underscoring a significant and growing healthcare challenge. The World Health Organization (WHO) played an active role in interpreting data from the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021, offering critical insights to inform strategic healthcare planning and investment decisions across both public and private sectors. EVD is a crucial medical device used in the management of conditions like hydrocephalus, traumatic brain injuries, and intracranial hemorrhage. In 2019, traumatic brain injury (TBI) accounted for 27.16 million new cases globally, with 48.99 million individuals living with the condition and 7.08 million years lived with disability (YLDs). In parallel, spinal cord injury (SCI) recorded 0.91 million new cases, 20.64 million prevalent cases, and 6.20 million YLDs. One of the primary drivers of the Global Acute EVD Market is the increasing incidence of neurological disorders worldwide. Neurological conditions, such as hydrocephalus, which involves the accumulation of cerebrospinal fluid in the brain, often require surgical intervention, including the use of EVDs. Additionally, traumatic brain injuries and intracranial hemorrhages, which can result from accidents or falls, necessitate immediate medical attention, leading to an increased demand for EVDs.

Key Market Challenges

Regulatory Compliance and Quality Assurance

One of the primary challenges in the EVD market is ensuring compliance with rigorous regulatory requirements and maintaining high-quality standards. These devices are critical for patient safety, and any flaws in design, manufacturing, or usage can have severe consequences. Manufacturers must adhere to strict guidelines set by regulatory bodies like the FDA and CE (Conformite Europeene) in Europe. Ensuring compliance while striving for innovation is a delicate balance that EVD companies must navigate.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed remarkable transformations in recent years, largely driven by technological advancements that have revolutionized patient care, diagnosis, and treatment. One area where these advancements are making a significant impact is in the field of neurosurgery and critical care. The Global Acute External Ventricular Drain (EVD) Market is experiencing substantial growth due to the integration of cutting-edge technologies, making it an integral component of modern medical practice. Recent advancements in material science and engineering have led to the development of smaller, lightweight, and biocompatible EVD devices. Miniaturized EVDs offer several benefits, including reduced infection risk, ease of placement, and patient comfort. Additionally, these devices are less obtrusive, making them more patient-friendly while providing healthcare professionals with enhanced monitoring capabilities.

Wireless technology has brought a new dimension to EVD management. Modern EVD systems are equipped with wireless sensors and connectivity options that allow real-time monitoring and remote data access. This enables healthcare providers to closely monitor patients' ICP and CSF pressure without being physically present, making it especially valuable in telemedicine and remote patient management scenarios. Artificial intelligence (AI) and machine learning algorithms have made significant inroads in healthcare, including the neurosurgical field. AI-powered EVD systems can analyze vast amounts of data, providing insights into trends and patterns in ICP and CSF pressure. This data-driven approach allows for more precise prediction of critical events and timely interventions, potentially saving lives and improving patient outcomes. Infections associated with EVDs have been a long-standing concern. However, technological advancements have led to the development of EVDs with enhanced infection control features. Antimicrobial-coated catheters, closed drainage systems, and sterile insertion techniques have significantly reduced the risk of infections associated with EVD placement, improving patient safety.

Key Market Players

• Medtronic plc
• Integra LifeSciences Corporation
• Natus Medical Incorporated
• Fuji Systems Corporation
• Spiegelberg GmbH
• SOPHYSA inc.
• Neuromedex inc.

Report Scope:

In this report, the Global Acute External Ventricular Drain Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Acute External Ventricular Drain Market, By Application:

• Traumatic Brain Injury (TBI)
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Others

Acute External Ventricular Drain Market, By Patient Type:

• Pediatric
• Adult

Acute External Ventricular Drain Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Acute External Ventricular Drain Market.

Available Customizations:

Global Acute External Ventricular Drain market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Acute External Ventricular Drain Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Traumatic Brain Injury (TBI), Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Others)
  • 5.2.2. By Patient Type (Pediatric, Adult)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Acute External Ventricular Drain Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Patient Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Acute External Ventricular Drain Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Patient Type
  • 6.3.2. Canada Acute External Ventricular Drain Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Patient Type
  • 6.3.3. Mexico Acute External Ventricular Drain Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Patient Type

7. Europe Acute External Ventricular Drain Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Patient Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Acute External Ventricular Drain Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Patient Type
  • 7.3.2. United Kingdom Acute External Ventricular Drain Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Patient Type
  • 7.3.3. Italy Acute External Ventricular Drain Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Patient Type
  • 7.3.4. France Acute External Ventricular Drain Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Patient Type
  • 7.3.5. Spain Acute External Ventricular Drain Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Patient Type

8. Asia-Pacific Acute External Ventricular Drain Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Patient Type
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Acute External Ventricular Drain Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Patient Type
  • 8.3.2. India Acute External Ventricular Drain Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Patient Type
  • 8.3.3. Japan Acute External Ventricular Drain Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Patient Type
  • 8.3.4. South Korea Acute External Ventricular Drain Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Patient Type
  • 8.3.5. Australia Acute External Ventricular Drain Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Patient Type

9. South America Acute External Ventricular Drain Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Patient Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Acute External Ventricular Drain Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Patient Type
  • 9.3.2. Argentina Acute External Ventricular Drain Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Patient Type
  • 9.3.3. Colombia Acute External Ventricular Drain Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Patient Type

10. Middle East and Africa Acute External Ventricular Drain Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Patient Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Acute External Ventricular Drain Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Patient Type
  • 10.3.2. Saudi Arabia Acute External Ventricular Drain Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Patient Type
  • 10.3.3. UAE Acute External Ventricular Drain Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Patient Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Acute External Ventricular Drain Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Medtronic plc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Integra LifeSciences Corporation
• 14.3. Natus Medical Incorporated
• 14.4. Fuji Systems Corporation
• 14.5. Spiegelberg GmbH
• 14.6. SOPHYSA inc.
• 14.7. Neuromedex inc.

15. Strategic Recommendations

16. About Us & Disclaimer